Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism (Q40883356)

24 September 2017

Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism (English)

1 reference

24 September 2017

1 reference

1 reference

Yousef Almehmadi

1

1 reference

PubMed ID

26030350

24 September 2017

Dany-Jan Yassin

series ordinal

2

1 reference

PubMed ID

26030350

24 September 2017

Aksam A Yassin

series ordinal

3

1 reference

24 September 2017

1 June 2015

1 reference

24 September 2017

1 reference

24 September 2017

18

1 reference

24 September 2017

3

1 reference

24 September 2017

186-194

1 reference

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

24 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Sex steroid hormone levels and body composition in men

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone and metabolic syndrome: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone replacement therapy for older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Significance of hypogonadism in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Does testosterone have a role in erectile function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Impotence and aging: clinical and hormonal factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The impact of age, body mass index and testosterone on erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Sexual function in men older than 50 years of age: results from the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Glycosylated haemoglobin levels and the severity of erectile function in diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The evolving role of testosterone in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone deficiency: a risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Andropause and quality of life: findings from patient focus groups and clinical experts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Metabolic risk factors, endothelial dysfunction, and erectile dysfunction in men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Gender differences in the regulation of vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Not all body fat weighs equally in the acceleration of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Testosterone: a vascular hormone in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Beyond BMI: The value of more accurate measures of fatness and obesity in social science research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

Prevalencia de disfunción eréctil en pacientes con hipertensión arterial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1046044

10.3109/13685538.2015.1046044

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

26030350